Ajinomoto Co Inc
TSE:2802
Ajinomoto Co Inc
Other Equity
Ajinomoto Co Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ajinomoto Co Inc
TSE:2802
|
Other Equity
¥156.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yakult Honsha Co Ltd
TSE:2267
|
Other Equity
¥36.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Meiji Holdings Co Ltd
TSE:2269
|
Other Equity
¥47.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
|
|
Kikkoman Corp
TSE:2801
|
Other Equity
¥64.2B
|
CAGR 3-Years
150%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
Other Equity
¥64.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
27%
|
|
|
Toyo Suisan Kaisha Ltd
TSE:2875
|
Other Equity
¥54.4B
|
CAGR 3-Years
132%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
20%
|
|
Ajinomoto Co Inc
Glance View
Ajinomoto Co., Inc., a household name synonymous with umami, has woven a rich tapestry in the fabric of the global food industry. Originally starting its journey in 1908, the company was founded by Dr. Kikunae Ikeda, who isolated and identified the flavor-enhancing properties of monosodium glutamate (MSG). It began its commercial journey by marketing this unique seasoning under the brand name "Ajinomoto," which translates to "essence of taste" in Japanese. Building upon this foundation, Ajinomoto has expanded far beyond MSG, leveraging its biochemical prowess to create a diverse range of food products and ingredients. This transition from a single product line to a multitude of culinary offerings has established Ajinomoto as a global leader in the food industry, catering to numerous markets with products that enhance the flavors of everyday meals. More than just a staple in pantries worldwide, Ajinomoto delves into the scientific realm of food and health. Its business model capitalizes not only on traditional seasoning products but also on innovative solutions in amino acids and wellness markets. The company generates revenue by harnessing biotechnologies to produce amino acids for pharmaceuticals, nutritional supplements, and the burgeoning wellness industry. Ajinomoto combines its biochemical expertise with a deep understanding of consumer trends to develop novel products that align with health and sustainability. Its strategic investments in technology and research empower the company to navigate contemporary challenges, ensuring its relevance and growth in an evolving marketplace. Through this dual focus on taste and health, Ajinomoto maintains its charismatic presence from bustling markets in Japan to homes across the globe.
See Also
What is Ajinomoto Co Inc's Other Equity?
Other Equity
156.4B
JPY
Based on the financial report for Dec 31, 2024, Ajinomoto Co Inc's Other Equity amounts to 156.4B JPY.
What is Ajinomoto Co Inc's Other Equity growth rate?
Other Equity CAGR 1Y
118%
Over the last year, the Other Equity growth was 118%.
You don't have any saved screeners yet